FDI proposals worth Rs.1,310 crore approved The government has approved 14 proposals of foreign direct investment amounting to a total of Rs. 1,310.60 crore
New Delhi, Jan 11: The government has approved 14 proposals of foreign direct investment (FDI) amounting to Rs.1,310.60 crore.
“Based on the recommendations of Foreign Investment Promotion Board (FIPB) in its meeting held on Dec 21, 2012, the government has approved 14 proposals of FDI amounting to Rs.1310.60 crore approximately,” the finance ministry said in a statement Friday.
The largest fund inflow is related to Mumbai-based shipping firm Hindustan Port Private Limited. The company has got approval to induct Rs.440 crore overseas fund for making downstream investment in other Indian companies.
A Mumbai-based pharmaceutical firm Aanjaneya Lifecare Limited has got approval to issue Foreign Currency Convertible Bonds to eligible foreign investors amounting Rs.405 crore.
Bangalore-based Syngene International Limited has got approval to induct Rs.125 crore foreign equity.
The government has rejected three proposals, while decision on six proposals have been deferred.
Dr Kannan Vishwanath founded Aanjaneya Lifecare Limited in 2006. He has completed his Chemical Engineering in Pune & Masters & Doctorate of Philosophy in Business Management from University of Azteca. He has over 12 years Experience in Pharmaceutical Industry with expertise in Licensing, Business Development, API, Generics, Finished Dose, Intermediates, marketing, production, distribution, licensing, outsourcing, contract development, formulation development, Patience ans Risk Taking are among the motivational factors applied by Dr Vishwanath and they have helped the company to learn from past mistakes and in making better decisions in future. A believer in fair practices, this visionary leader always offers his hand when needed regardless a friend or foe. Dr Vishwanath believes: “when you have a dream , don’t let anything dim it . Keep hoping, keep trying , for Sky is the Limit.
Coming from a very humble beginning with just 40 employees and small manufacturing facility for anti malarial drugs over 6 years ago , Dr Vishwanath has achieved exceptional results through developing and redefining the business roadmap, ensuring differentiation as a competitive advantage and clearly focusing on the brands consumers want and the products consumers need . Anjaneya Lifecare Limited (ALL ) produces & markets a range of pharmaceutical products across the globe . With two facilities in Maharashtra state employing over 300 people the company delivers essential products for every day life under the brands Rankorex, Prosils, DocTor quore, Esyhil, amongst others. The company has over 200 distributors pan India for its Branded Generic products & exports to over 40 countries with sales in excess of 320 crores. Under Dr Vishwanath’s leadership, the marketind, reachersh & product development departments were expanded . The company has been growing at CAGR of 175 % for last 5 years and is now the third largest manufacturer of Quinine salts in world. ALL has received many awards and accolades which recognize its brands and product excellence , such as the Green Business of the year-2011 at Emerging India Awards by ICICI Bank & CNBC TV 18 & voted among the top 100 company in “ India’s Best Companies to Work With -2011 “.Aanjaneya’s global accolades …position Aanjaneya it differently. We started the tough way. We proactively institutionalised best-in-league systems and processes. And consumers around the globe vindicated our approach. The result: we are partners with a number of global pharma leaders. We started the tough way. We proactively institutionalized best-in-league systems and processes. And the globe vindicated our approach. The result: we are partners with global pharma leaders.
About Aanjaneya Lifecare Limited:
Aanjaneya Lifecare Limited is a vertically integrated company having state-of-the-art; WHO GMP approved facilities for manufacturing bulk drugs at Mahad and finished dosage forms at Pirungut near Pune. It is one of the largest contract manufacturers of codeine based cough syrups in India. The company exclusively manufactures the Codorex Brand of Zydus Cadilla and Codilite Brand of Tablets India Ltd. amongst others.
Aanjaneya Lifecare Limited, a vertically integrated pharmaceutical company with manufacturing and marketing capabilities in APIs (Active Pharmaceutical Ingredients) with focus on anti-malarial, and finished dosage forms (FDFs) catering to various therapeutic segments.The company is the third largest Quinine Salts manufacturer in the world.
The company recently raised about Rs. 117 crore from its IPO and the funds are being used to built new capacities along with the refurbishing of Research & Development centre. The new facilities being created as part of CAPEX are using eco friendly, recyclable material and will be rated by LEEDS once completed, company sources informed. The Facilities being established will comply with the latest European & US guidelines. With new capacities to be added in next 6 to 9 months the company will be expanding operations in emerging markets of South East Asia, Africa & South & Central America and its domestic operation in branded generics segment.
Landmark Awards for Aanjaneya Lifecare Ltd.
- India’s Most technically & scientifically advanced Pharmaceutical Manufacturing unit of the year 2011 at 4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2011
- Emerging Company of the Year 2011 at 4th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2011
- Gold Certification for its Annual Report at the LACP 2012 Global Communications Spotlight Awards Held in Florida USA
- India’s Most Valuable Company on “Corporate Governance, Ethical Practice & Sustainability Vision” Award at 3rd Annual India Leadership Conclave & Business Leadership Awards 2012.
- ‘IMC Ramakarishna Bajaj Award 2012’. one of the most prestigious Quality awards in India. The company got recognised as one of the leading and fastest growing integrated pharma companies in India.
- BSE Award for Best Return to Investors 2012 at 5th Annual Pharmaceutical Leadership Summit & Business Leadership Awards 2012.
- Aanjaneya Lifecare Limited ranked No 2 Industry wise & 9th Position in the Asia- Pacific region at The Global Investor Relations Summit.
No comments:
Post a Comment